LifeStance Health Group Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $1.6B+26.7% YoYTTM through 30 Jun 2026
Net Income $50.6MTTM through 30 Jun 2026
Free Cash Flow $173.9MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| EBITDA Margin | 7.6% |
| Operating Margin | 5.5% |
| Net Margin | 3.2% |
Returns
1.6%ROE
1.1%ROA
3.3%ROIC
Balance Sheet Health
Debt / Equity0.19x
Current Ratio1.38x
Net Debt$88M
Cash & Equivalents$225.9M
Quality Metrics
Altman Z-Score4.47
Piotroski F-Score6 / 9
FCF Margin11.0%
Rule of 4018.7
Earnings-Beat Rate50.0%
Multi-Year Trend
RevenueFY2025: $1.4B
Diluted EPSFY2025: $0.02
Dividend
No dividend
Capital Allocation
Capex Intensity2.8%
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.